Newsroom |  Contact Us

CHF Solutions in the News

CHF Solutions, Inc. Expands European Distribution with New Agreement in Italy

Posted on

EDEN PRAIRIE, Minn., April 17, 2018 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (Nasdaq:CHFS) announced today further expansion into the European markets with the initiation of a new distribution agreement with TRX Italy, S.r.I. to distribute the company’s Aquadex FlexFlow System in Italy. “According to the World Health Organization there are more than twice as many acute decompensated heart failure patients in Western Europe than […]

Read More

CHF Solutions, Inc. Expands Operations into Hong Kong; Receives First Commercial Orders for Both Hong Kong and Singapore

Posted on

EDEN PRAIRIE, Minn., April 12, 2018 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (Nasdaq:CHFS) announced today its commercial expansion into the Hong Kong market through its Asia distributor, Transmedic.  Further, Transmedic has confirmed its first commercial orders for both Singapore and Hong Kong. “Our expansion into the Asian markets is a key factor in our commercialization strategy, and our distribution partner, Transmedic, has flawlessly initiated on executing […]

Read More

Recently Published CARRESS-HF Per Protocol Analysis Demonstrates Greater Fluid Reduction in Heart Failure Patients Using CHF Solutions’ Aquadex FlexFlow System

Posted on

EDEN PRAIRIE, Minn., April 10, 2018 (GLOBE NEWSWIRE) — A recently published study in the European Journal of Heart Failure highlighted a per protocol analysis of the CARRESS-HF study, which demonstrated that ultrafiltration with the Aquadex Flex Flow System by CHF Solutions, Inc. (Nasdaq:CHFS) was associated with a higher cumulative fluid loss (p=0.003), higher net fluid loss (p=0.001) and greater relative […]

Read More

CHF Solutions, Inc. Begins New Educational Program, “Facing the Facts about Fluid Overload” to Demonstrate the Need for Aquadex Therapy

Posted on

EDEN PRAIRIE, Minn., March 29, 2018 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (Nasdaq: CHFS) announced today the launch of a new educational program, “Facing the Facts About Fluid Overload,” designed to inform providers about an alternative ultrafiltration therapy for heart failure patients with fluid overload who have failed diuretic therapy. “Intravenous diuretics have been the standard of care for […]

Read More

Sunshine Heart: German Reimbursement Update

Posted on

InEK, the German Institute for the Hospital Remuneration System granted on January 29th, 2016 a NUB (Neue Untersuchungs-und Behandlungsmethoden) status 4 designation for the C-Pulse® System in heart failure. The purpose of the NUB process is to introduce new and innovative medical products prior to reimbursement being available. It is also the preferred path to […]

Read More

CHF Solutions